Status:
UNKNOWN
Non-contrast MR Imaging for Whole Body Cancer Detection and Characterization
Lead Sponsor:
University of California, San Diego
Collaborating Sponsors:
Prostate Cancer Foundation
United States Department of Defense
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This study aims to learn how to improve MRIs (Magnetic Resonance Imaging) that do not require the patient to be injected with a contrast dye. Researchers expect to learn how to better find and describ...
Detailed Description
Participants will undergo a whole body non-contrast MRI study with a whole-body protocol incorporating routine clinical sequences as well as non-contrast research sequences. The patient will also unde...
Eligibility Criteria
Inclusion
- Patients must have known or suspected genitourinary metastatic disease and have already had or will have a CT, PET/CT, bone scan or MRI with contrast.
- Age ≥ 18 years.
- ECOG performance status 0-3.
- Capacity to give informed consent.
- Ability to lay supine for 30-60 minutes
- Ability to hear adequately without hearing aids.
Exclusion
- Patients with medical implants/devices or indwelling foreign material considered unsafe for MRI scanning will be excluded. Safety of medical implants/devices will be determined by the current UC San Diego Radiology and Imaging Services MRI safety policy. The name, manufacturer, and model number of any medical implant/device contained within a potential study subject will be obtained and reviewed to determine safety. Patients will be excluded if any implant/device is found to be unsafe for MRI scanning.
- Patients may be excluded if their weight exceeds 350 lbs, the limit for the safe operation of the MRI scanning table.
- A patient who is pregnant or trying to become pregnant will be excluded.
- Patients with any other condition that, in the opinion of the investigator, may deem them ineligible for study participation.
Key Trial Info
Start Date :
March 24 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03440554
Start Date
March 24 2016
End Date
January 1 2023
Last Update
April 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC San Diego Moores Cancer Center
La Jolla, California, United States, 92093